PaulLorenSwiecickiMD

PubMed

• PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.
  Rodriguez, C., Kang, H., Babbar, N., Sun, W., Ferrarotto, R., Swiecicki, P., Zandberg, D., Baiocchi, R., Wesolowski, R., McKean, M., Monga, V., Nath, R., Palmisiano, N...> ;Oral Oncology. 2024 Feb 1
• Doublet Therapy: Two Narrative Accounts of One Life-Changing Decision.
  Victoria A Wytiaz, Paul Swiecicki> ;JCO Oncology Practice. 2024 Jan 1
• 5 citations
  Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
  Neil D Gross, David M Miller, Nikhil I Khushalani, Vasu Divi, Emily S Ruiz, Evan J Lipson, Friedegund Meier, Yungpo Bernard Su, Paul L Swiecicki, Jennifer Atlas, Jessi...> ;The Lancet. Oncology. 2023 Nov 1
• Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma.
  Megan L Ludwig, Nicole L Michmerhuizen, Jiayu Wang, Andrew C Birkeland, Behirda K Majchrowski, Sai Nimmagadda, Jingyi Zhai, Apurva Bhangale, Aditi Kulkarni, Hui Jiang,...> ;Archives of Oral Biology. 2023 Dec 1
• 3 citations
  Prognostic value of CD103tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma.
  Joshua D Smith, Emily L Bellile, Susan E Ellsperman, Molly E Heft-Neal, Jacqueline E Mann, Andrew C Birkeland, Rebecca C Hoesli, Paul L Swiecicki, Francis P Worden, Ca...> ;Oral Oncology. 2022 Dec 1
• Mitotic Checkpoints and the Role of WEE1 Inhibition in Head and Neck Squamous Cell Carcinoma.
  Shihan N Khan, Paul L Swiecicki, Deborah B Doroshow> ;Cancer Journal. 2022 Sep 27
• 3 citations
  Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer.
  Michelle L Mierzwa, Madhava Aryal, Choonik Lee, Matthew Schipper, Monica VanTil, Krystal Morales, Paul L Swiecicki, Keith A Casper, Kelly M Malloy, Matthew E Spector, ...> ;Clinical Cancer Research. 2022 Dec 1
• 1 citations
  Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.
  Paul L Swiecicki, Emily Bellile, Keith Casper, Steven Bennett Chinn, Aleksandar F Dragovic, Shruti Jolly, Robbi Kupfer, Kelly M Malloy, Michelle Lynn Mierzwa, Andrew G...> ;Head & Neck. 2022 Jul 1
• 3 citations
  Risk of obstructive sleep apnea after treatment of head and neck squamous cell carcinoma: a cross-sectional study.
  Ronald Gavidia, Galit Levi Dunietz, Louise M O'Brien, Sonja G Schütz, Matthew E Spector, Paul L Swiecicki, Ronald D Chervin> ;Journal of Clinical Sleep Medicine. 2022 Jun 1
• Patient and Provider Perspectives on Enrollment in Precision Oncology Research: Qualitative Ethical Analysis.
  Kayte Spector-Bagdady, Madison Kent, Chris D Krenz, Collin Brummel, Paul L Swiecicki, J Chad Brenner, Andrew G Shuman> ;JMIR Cancer. 2022 May 3
• 4 citations
  Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma.
  Nicole L Michmerhuizen, Megan L Ludwig, Andrew C Birkeland, Sai Nimmagadda, Jingyi Zhai, Jiayu Wang, Brittany M Jewell, Dylan Genouw, Lindsay Remer, Daniel Kim, Susan ...> ;Head & Neck. 2022 May 1
• Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials.
  Laila A Gharzai, Julia Pakela, Elizabeth M Jaworski, Issam El Naqa, Jennifer Shah, Peter G Hawkins, Matthew E Spector, Carol R Bradford, Steven B Chinn, Kelly Malloy, ...> ;Clinical and Translational Radiation Oncology. 2022 Mar 1
• 9 citations
  Trans-Renal Cell-Free Tumor DNA for Urine-Based Liquid Biopsy of Cancer.
  Sarah M Dermody, Chandan Bhambhani, Paul L Swiecicki, J Chad Brenner, Muneesh Tewari> ;Frontiers in Genetics. 2022 Jan 1
• 30 citations
  Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma
  Yue Cao, Catherine T. Haring, Collin Brummel, Chandan Bhambhani, Madhava P. Aryal, Choonik Lee, Molly E. Heft Neal, Apurva D. Bhangale, Wenjin Gu, Keith A. Casper, Kel...> ;Clinical Cancer Research. 2021 Oct 26
• 1 citations
  A Consideration for Surgical Management in Select T4b Oral Cavity Squamous Cell Carcinoma.
  Michelle M. Chen, Clifford M. Chang, Sarah M. Dermody, Andrew J. Rosko, Michelle Mierzwa, Paul L. Swiecicki, Matthew E. Spector, Francis P. Worden, Mark E. Prince, Ste...> ;The Annals of Otology, Rhinology, and Laryngology. 2021 Aug 7
• 34 citations
  Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma.
  Catherine T. Haring, Chandan Bhambhani, Collin Brummel, Brittany M. Jewell, Emily Bellile, Molly E. Heft Neal, Erin Sandford, Ryan M. Spengler, Apurva D. Bhangale, Mat...> ;Oncotarget. 2021 Jun 22
• 16 citations
  Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial.
  Alon Kahana, Shelby P. Unsworth, Chris Andrews, May P. Chan, Scott C. Bresler, Christopher K. Bichakjian, Alison B. Durham, Hakan Demirci, Victor M. Elner, Christine C...> ;The Oncologist. 2021 Jul 1
• 2 citations
  Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing Bioselection.
  Molly E. Heft Neal, Joshua D. Smith, Andrew C. Birkeland, Catherine T. Haring, Steven B. Chinn, Andrew G. Shuman, Keith A. Casper, Kelly M. Malloy, Chaz L. Stucken, Sc...> ;Otolaryngology--Head and Neck Surgery. 2021 May 25
• 100 citations
  Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, pha...
  Assuntina G. Sacco, Ruifeng Chen, Francis P. Worden, Deborah J.L. Wong, Douglas Adkins, Paul L. Swiecicki, Wanxing Chai-Ho, Peter Oppelt, Debanjali Ghosh, Julie Bykows...> ;The Lancet. Oncology. 2021 Jun 1
• 115 citations
  Management of Salivary Gland Malignancy: ASCO Guideline.
  Jessica L. Geiger, Nofisat Ismaila, Beth M. Beadle, Jimmy J. Caudell, Nicole G. Chau, Daniel G. Deschler, Christine M. Glastonbury, Marnie Kaufman, Eric Lamarre, Harol...> ;Journal of Clinical Oncology. 2021 Apr 26
• 6 citations
  Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal Cancer.
  L.A. Gharzai, N. Burger, Pin Li, E. Jaworski, Caitlin Henderson, Matthew E. Spector, Andy Rosko, Michelle M. Chen, Mark E. Prince, Carol R. Bradford, Kelly M. Malloy, ...> ;The Oncologist. 2021 Aug 1
• 9 citations
  Obstructive sleep apnea in patients with head and neck cancer: a systematic review
  Ronald Gavidia, Galit Levi Dunietz, Louise M. O'Brien, Carol Shannon, Sonja Schuetz, Matthew E. Spector, Paul L. Swiecicki, Ronald D. Chervin> ;Journal of Clinical Sleep Medicine. 2021 May 1
• 3 citations
  Surveillance and Monitoring Techniques for HPV-Related Head and Neck Squamous Cell Carcinoma: Circulating Tumor DNA
  Sarah M. Dermody, Catherine T. Haring, Chandan Bhambhani, Muneesh Tewari, J. Chad Brenner, Paul L. Swiecicki> ;Current Treatment Options in Oncology. 2021 Feb 8
• 7 citations
  Prediction of Disease Free Survival in Laryngeal and Hypopharyngeal Cancers Using CT Perfusion and Radiomic Features: A Pilot Study.
  Sean Woolen, Apurva Virkud, Lubomir M. Hadjiiski, Kenny H. Cha, Heang Ping Chan, Paul L. Swiecicki, Francis P. Worden, Ashok Srinivasan> ;Tomography. 2021 Feb 5
• 8 citations
  CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
  B.S. Rosen, J.R. Wilkie, Yilun Sun, Mohannad Ibrahim, Keith A. Casper, Jessa E Miller, Thong Chotchutipan, Chaz L. Stucken, Carol R. Bradford, Mark E. Prince, Andrew J...> ;Radiotherapy and Oncology. 2021 Feb 1
• Join now to see all